RESEARCH-USE BIOSIMILAR ANTIBODY
Maftivimab
Monoclonal antibody · IgG1
Maftivimab (REGN3470-3471-3479) is a human monoclonal antibody targeting the glycoprotein of Zaire ebolavirus (ZEBOV), with an IC50 of 0.17 nM and a Kd of 2.97 nM. Maftivimab is applicable to research related to Zaire ebolavirus infection and Ebola virus disease.
TARGETZaire Ebolavirus GP
YMonoclonal antibody
CATALOGSC-BS-400
CATALOG NUMBERSC-BS-400
MOLECULAR WEIGHTApprox. 143.94 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Maftivimab (REGN3470-3471-3479) is a human monoclonal antibody targeting the glycoprotein of Zaire ebolavirus (ZEBOV), with an IC50 of 0.17 nM and a Kd of 2.97 nM. Maftivimab is applicable to research related to Zaire ebolavirus infection and Ebola virus disease.
Maftivimab is a recombinant research-use antibody directed against Zaire Ebolavirus GP.